Resumen de Investigación
Nutritional Therapy and AGIs Improve Postprandial Glucose in Diabetes
Moderate confidence
Low bias
Última actualización 15 de junio de 2026Conclusión Clave:
This study compared the effectiveness of nutritional therapy and alpha-glucosidase inhibitors in managing type 2 diabetes, finding significant reductions in glucose levels with both interventions.
Estudio de un Vistazo
Participantes
Intervención
Acarbose 50 mg, Voglibose 0.3 mg, Low glycemic index diet, Regular diet
Resultados
Postprandial mean glucose, 24-hour mean glucose, Mean amplitude of glycemic excursion (MAGE), Area under the curve for 24-hour glycemic fluctuations, Incidence of hypoglycemia
Financiamiento
No Patrocinado por la Industria
Guarda este estudio y agrega notas a tu biblioteca de investigación.
Efectos Principales
Postprandial mean glucose levels decreased by 2.5 mg/dL (p=0.001).
24-hour mean glucose levels decreased by 3 mg/dL (p=0.001).
The proportion of participants achieving target PPG (<180 mg/dl) increased by 50% (p=0.001).
Resumen de Evidencia
| Intervention | Outcome | Measured Change | Study Effect |
|---|---|---|---|
 Acarbose (Medications) |  24-hour glucose (Glycemic Control) | Decrease | Strong |
Acarbose (Medications) | Glucose area under the curve (AUC) (Glycemic Control) | Decrease | Strong |
Acarbose (Medications) | Mean amplitude of glycemic excursions (MAGE) (Glycemic Control) | Decrease | Strong |
Acarbose (Medications) | Postprandial blood glucose (Glycemic Control) | Decrease | Strong |
Acarbose (Medications) |  Postprandial hypoglycemia incidence (Safety) | No Change | Unclear |
 Low glycemic index treatment (LGIT) (Diet and Nutrition) | 24-hour glucose (Glycemic Control) | Decrease | Strong |
Low glycemic index treatment (LGIT) (Diet and Nutrition) | Glucose area under the curve (AUC) (Glycemic Control) | Decrease | Strong |
Low glycemic index treatment (LGIT) (Diet and Nutrition) | Mean amplitude of glycemic excursions (MAGE) (Glycemic Control) | Decrease | Strong |
Low glycemic index treatment (LGIT) (Diet and Nutrition) | Postprandial blood glucose (Glycemic Control) | Decrease | Strong |
Voglibose (Medications) | 24-hour glucose (Glycemic Control) | Decrease | Strong |
Voglibose (Medications) | Glucose area under the curve (AUC) (Glycemic Control) | Decrease | Strong |
Voglibose (Medications) | Mean amplitude of glycemic excursions (MAGE) (Glycemic Control) | Decrease | Strong |
Voglibose (Medications) | Postprandial blood glucose (Glycemic Control) | Decrease | Strong |
Voglibose (Medications) | Postprandial hypoglycemia incidence (Safety) | No Change | Unclear |
Unlock Full Evidence Analysis
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
La Evidencia Sugiere
- Postprandial mean glucose significantly reduced with interventions.
- 24-hour mean glucose levels were notably lower, especially with acarbose.
- Higher proportion of participants reached target PPG levels with acarbose.
A quién se aplica
- Adults diagnosed with type 2 diabetes.
- Individuals seeking dietary and pharmaceutical options for blood sugar management.
Tener en Cuenta
- Results may not apply to all demographics due to study population.
- Effectiveness may vary based on individual adherence to dietary changes.
- Further research needed to explore long-term outcomes and safety.
Entre Líneas
- Limited generalizability due to specific population characteristics.
- Potential confounding factors not fully controlled.
- Short duration of follow-up may not capture long-term effects.
Unlock Full Analysis
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Already have an account?
Referencia de la Revista
Alexander M, John RA, Praveen RS, Anudeep G, Shivaraj SH. Comparative Effectiveness of Nutritional Therapy and Alpha-Glucosidase Inhibitors in Type 2 Diabetes Management. Cureus. 2026;18(4):e106557. doi:10.7759/cureus.106557
Connected Evidence
Discover how this study fits into the broader diabetes evidence landscape.
This study contributes to evidence on Alpha-glucosidase inhibitors and Glycemic Control, Alpha-glucosidase inhibitors and Glycemic Control.
Relaciones de evidencia relacionadas
Explore in Evidence ArchiveThis study contributes to the evidence on the following intervention–outcome relationships.
Incluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
Alpha-glucosidase inhibitors Evidence Hub
All studies on Alpha-glucosidase inhibitors
1 studies
intervention_hubContributes to Alpha-glucosidase inhibitors evidence base.
Glycemic Control Evidence Hub
All studies measuring Glycemic Control
1 studies
outcome_hubMeasures Glycemic Control as a key outcome.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explora más en el archivo de evidencia
Jump to pre-filtered views in the evidence archive.
All studies on Acarbose and 24-hour glucose
Intervention: AcarboseOutcome: 24-hour glucose
1 results
All studies on Acarbose and Glucose area under the curve (AUC)
Intervention: AcarboseOutcome: Glucose area under the curve (AUC)
1 results
All studies on Acarbose
Intervention: Acarbose
1 results
All studies measuring 24-hour glucose
Outcome: 24-hour glucose
1 results
All studies measuring Glucose area under the curve (AUC)
Outcome: Glucose area under the curve (AUC)
1 results
Preguntas que esta evidencia ayuda a responder
Key clinical and research questions this study contributes to.
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.